These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
282 related articles for article (PubMed ID: 20528079)
61. Prenatal Administration of Oleic Acid or Linolenic Acid Reduces Neuromorphological and Cognitive Alterations in Ts65dn Down Syndrome Mice. García-Cerro S; Rueda N; Vidal V; Puente A; Campa V; Lantigua S; Narcís O; Velasco A; Bartesaghi R; Martínez-Cué C J Nutr; 2020 Jun; 150(6):1631-1643. PubMed ID: 32243527 [TBL] [Abstract][Full Text] [Related]
62. Defects in embryonic neurogenesis and initial synapse formation in the forebrain of the Ts65Dn mouse model of Down syndrome. Chakrabarti L; Galdzicki Z; Haydar TF J Neurosci; 2007 Oct; 27(43):11483-95. PubMed ID: 17959791 [TBL] [Abstract][Full Text] [Related]
63. Maternal choline supplementation during the third trimester of pregnancy improves infant information processing speed: a randomized, double-blind, controlled feeding study. Caudill MA; Strupp BJ; Muscalu L; Nevins JEH; Canfield RL FASEB J; 2018 Apr; 32(4):2172-2180. PubMed ID: 29217669 [TBL] [Abstract][Full Text] [Related]
64. Abnormal APP, cholinergic and cognitive function in Ts65Dn Down's model mice. Seo H; Isacson O Exp Neurol; 2005 Jun; 193(2):469-80. PubMed ID: 15869949 [TBL] [Abstract][Full Text] [Related]
65. Neuroanatomical alterations and synaptic plasticity impairment in the perirhinal cortex of the Ts65Dn mouse model of Down syndrome. Roncacé V; Burattini C; Stagni F; Guidi S; Giacomini A; Emili M; Aicardi G; Bartesaghi R Neurobiol Dis; 2017 Oct; 106():89-100. PubMed ID: 28651891 [TBL] [Abstract][Full Text] [Related]
66. Metabolic imprinting of choline by its availability during gestation: implications for memory and attentional processing across the lifespan. Meck WH; Williams CL Neurosci Biobehav Rev; 2003 Sep; 27(4):385-99. PubMed ID: 12946691 [TBL] [Abstract][Full Text] [Related]
67. Age-related deficits in context discrimination learning in Ts65Dn mice that model Down syndrome and Alzheimer's disease. Hyde LA; Crnic LS Behav Neurosci; 2001 Dec; 115(6):1239-46. PubMed ID: 11770055 [TBL] [Abstract][Full Text] [Related]
68. RvE1 treatment prevents memory loss and neuroinflammation in the Ts65Dn mouse model of Down syndrome. Hamlett ED; Hjorth E; Ledreux A; Gilmore A; Schultzberg M; Granholm AC Glia; 2020 Jul; 68(7):1347-1360. PubMed ID: 31944407 [TBL] [Abstract][Full Text] [Related]
69. Short- and long-term effects of neonatal pharmacotherapy with epigallocatechin-3-gallate on hippocampal development in the Ts65Dn mouse model of Down syndrome. Stagni F; Giacomini A; Emili M; Trazzi S; Guidi S; Sassi M; Ciani E; Rimondini R; Bartesaghi R Neuroscience; 2016 Oct; 333():277-301. PubMed ID: 27457036 [TBL] [Abstract][Full Text] [Related]
70. Chronic up-regulation of the SHH pathway normalizes some developmental effects of trisomy in Ts65Dn mice. Dutka T; Hallberg D; Reeves RH Mech Dev; 2015 Feb; 135():68-80. PubMed ID: 25511459 [TBL] [Abstract][Full Text] [Related]
71. Impaired plasticity at specific subset of striatal synapses in the Ts65Dn mouse model of Down syndrome. Di Filippo M; Tozzi A; Ghiglieri V; Picconi B; Costa C; Cipriani S; Tantucci M; Belcastro V; Calabresi P Biol Psychiatry; 2010 Apr; 67(7):666-71. PubMed ID: 19818432 [TBL] [Abstract][Full Text] [Related]
73. Low dose EGCG treatment beginning in adolescence does not improve cognitive impairment in a Down syndrome mouse model. Stringer M; Abeysekera I; Dria KJ; Roper RJ; Goodlett CR Pharmacol Biochem Behav; 2015 Nov; 138():70-9. PubMed ID: 26363314 [TBL] [Abstract][Full Text] [Related]
74. Lifespan analysis of brain development, gene expression and behavioral phenotypes in the Ts1Cje, Ts65Dn and Dp(16)1/Yey mouse models of Down syndrome. Aziz NM; Guedj F; Pennings JLA; Olmos-Serrano JL; Siegel A; Haydar TF; Bianchi DW Dis Model Mech; 2018 Jun; 11(6):. PubMed ID: 29716957 [TBL] [Abstract][Full Text] [Related]
75. Embryonic and not maternal trisomy causes developmental attenuation in the Ts65Dn mouse model for Down syndrome. Blazek JD; Billingsley CN; Newbauer A; Roper RJ Dev Dyn; 2010 Jun; 239(6):1645-53. PubMed ID: 20503361 [TBL] [Abstract][Full Text] [Related]
76. Choline, Neurological Development and Brain Function: A Systematic Review Focusing on the First 1000 Days. Derbyshire E; Obeid R Nutrients; 2020 Jun; 12(6):. PubMed ID: 32531929 [TBL] [Abstract][Full Text] [Related]
77. Maternal choline supplementation: a nutritional approach for improving offspring health? Jiang X; West AA; Caudill MA Trends Endocrinol Metab; 2014 May; 25(5):263-73. PubMed ID: 24680198 [TBL] [Abstract][Full Text] [Related]
78. Age exacerbates abnormal protein expression in a mouse model of Down syndrome. Ahmed MM; Block A; Tong S; Davisson MT; Gardiner KJ Neurobiol Aging; 2017 Sep; 57():120-132. PubMed ID: 28641136 [TBL] [Abstract][Full Text] [Related]
79. Neural stem cells reduce hippocampal tau and reelin accumulation in aged Ts65Dn Down syndrome mice. Kern DS; Maclean KN; Jiang H; Synder EY; Sladek JR; Bjugstad KB Cell Transplant; 2011; 20(3):371-9. PubMed ID: 20875225 [TBL] [Abstract][Full Text] [Related]
80. Ts65Dn mice, a model for Down syndrome, have deficits in context discrimination learning suggesting impaired hippocampal function. Hyde LA; Frisone DF; Crnic LS Behav Brain Res; 2001 Jan; 118(1):53-60. PubMed ID: 11163633 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]